gene_symbol
UNKNOWN
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
CAR on engineered NK cells binds the tumor antigen, triggering NK activation and killing antigen-positive cells via perforin/granzyme release and death-receptor pathways (FasL/TRAIL).
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
Study-specific CAR target antigen(s) not specified in the trial record; MHC-independent recognition
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06572956
disease_id_num_tar_ref
5107
drug_id_num_tar_ref
13828